ACADIA Pharmaceuticals
Price & Volume
Stats
See more52W Range | $19.69-$29.15 |
Market Cap | $4.9B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $1.1B |
Revenue Growth (YoY) | 16.4% |
Gross Profit (12 Mos) | $708.8M |
Diluted EPS | $2.21 |
News
See moreYahoo Finance • 2 days ago
Acadia outlines $480M-$510M 2026 DAYBUE sales outlook as remlifanserin Phase II data nears Sep-Oct
Yahoo Finance • 27 days ago
An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors?
Yahoo Finance • last month
Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer
Yahoo Finance • last month
Acadia rises as EU backs Rett syndrome therapy
About
CEO | Ms. Catherine E. Owen Adams |
CFO | Mr. Mark C. Schneyer |
Address | 12830 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 796 |